Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Non-Current Debt (2017 - 2025)

Historic Non-Current Debt for Dr Reddys Laboratories (RDY) over the last 10 years, with Q4 2025 value amounting to $195.9 million.

  • Dr Reddys Laboratories' Non-Current Debt changed N/A to $195.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $195.9 million, marking a year-over-year change of. This contributed to the annual value of $92.0 million for FY2025, which is 2777.78% up from last year.
  • Dr Reddys Laboratories' Non-Current Debt amounted to $195.9 million in Q4 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Non-Current Debt peaked at $195.9 million during Q4 2025, and registered a low of $87.73 during Q2 2022.
  • Moreover, its 5-year median value for Non-Current Debt was $87.1 million (2021), whereas its average is $85.5 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first plummeted by 9999.99% in 2022, then soared by 8396397140.54% in 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Non-Current Debt (Quarter) stood at $91.2 million in 2021, then fell by 17.26% to $75.5 million in 2022, then rose by 18.3% to $89.3 million in 2023, then decreased by 1.54% to $87.9 million in 2024, then skyrocketed by 122.9% to $195.9 million in 2025.
  • Its Non-Current Debt stands at $195.9 million for Q4 2025, versus $133.4 million for Q3 2025 and $100.7 million for Q1 2025.